We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

152 hedge funds and large institutions have $1.26B invested in Acorda Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 40

26% more capital invested

Capital invested by funds: $1B → $1.26B (+$258M)

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1% more funds holding

Funds holding: 151 → 152 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less call options, than puts

Call options by funds: $6.72M | Put options by funds: $8.28M

Holders
152
Holders Change
+1
Holders Change %
+0.66%
% of All Funds
3.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
61
Reduced
40
Closed
17
Calls
$6.72M
Puts
$8.28M
Net Calls
-$1.56M
Net Calls Change
+$10.6M

Top Buyers

1
PHS
PFM Health Sciences
California
+$32.1M
2
SCM
Scopia Capital Management
New York
+$27.5M
3
Invesco
Invesco
Georgia
+$15.4M
4
BBA
Baker Bros. Advisors
New York
+$11.4M
5
Deutsche Bank
Deutsche Bank
Germany
+$9.45M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$20.3M
2
CI
Cambiar Investors
Colorado
-$11.8M
3
GTC
Ghost Tree Capital
New York
-$7.88M
4
State Street
State Street
Massachusetts
-$6.39M
5
USAA
United Services Automobile Association
Texas
-$4.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
$1.06M -$134K -51 -12%
Massachusetts Financial Services
77
Massachusetts Financial Services
Massachusetts
$985K -$13.2K -5 -1%
State of Tennessee, Department of Treasury
78
State of Tennessee, Department of Treasury
Tennessee
$957K -$58K -22 -6%
VOYA Investment Management
79
VOYA Investment Management
Georgia
$944K +$424K +161 +94%
HighTower Advisors
80
HighTower Advisors
Illinois
$900K +$63.2K +24 +8%
MAM
81
Martingale Asset Management
Massachusetts
$878K +$227K +86 +39%
SO
82
STRS Ohio
Ohio
$877K -$119K -45 -13%
WT
83
Whittier Trust
California
$872K +$10.5K +4 +1%
AIG
84
American International Group
New York
$821K +$39.5K +15 +5%
TPSF
85
Texas Permanent School Fund
Texas
$805K – – –
DCM
86
Dupont Capital Management
Delaware
$804K – – –
State Board of Administration of Florida Retirement System
87
State Board of Administration of Florida Retirement System
Florida
$798K – – –
Manulife (Manufacturers Life Insurance)
88
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$783K -$13.2K -5 -2%
State of Wisconsin Investment Board
89
State of Wisconsin Investment Board
Wisconsin
$757K – – –
Wolverine Trading
90
Wolverine Trading
Illinois
$721K +$669K +254 New
ProShare Advisors
91
ProShare Advisors
Maryland
$713K +$36.9K +14 +6%
ERSOT
92
Employees Retirement System of Texas
Texas
$710K – – –
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$707K – – –
Public Sector Pension Investment Board (PSP Investments)
94
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$698K +$121K +46 +23%
VRS
95
Virginia Retirement Systems
Virginia
$683K +$350K +133 +123%
Thrivent Financial for Lutherans
96
Thrivent Financial for Lutherans
Minnesota
$675K +$10.5K +4 +2%
SAMH
97
Shanda Asset Management Holdings
British Virgin Islands
$614K +$350K +133 +160%
CCMH
98
Cornerstone Capital Management Holdings
New York
$601K -$867K -329 -61%
ASRS
99
Arizona State Retirement System
Arizona
$572K -$2.63K -1 -0.5%
BNP Paribas Financial Markets
100
BNP Paribas Financial Markets
France
$565K +$216K +82 +70%
2 3
4
5 6

ACOR Hedge Fund Activity: Q3 2017 in Review

152 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2017, worth a combined $1.26B — up 26% from $1B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ACOR positions and 17 closed out — a net gain of 1 holder — while 61 added to existing stakes and 40 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $32.1M. The largest seller was Citadel Advisors, cutting an estimated $20.3M.

  • 152 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2017, up from 151 in Q2 2017.
  • Funds reported $1.26B of Acorda Therapeutics stock for Q3 2017, up 26% quarter-over-quarter.
  • 18 funds opened new Acorda Therapeutics positions in Q3 2017 and 17 closed out, a net change of +1 holder.
  • The largest Acorda Therapeutics buyer in Q3 2017 was PFM Health Sciences, an estimated $32.1M added.
  • The largest Acorda Therapeutics seller in Q3 2017 was Citadel Advisors, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2017.